Deep Forest

Deep Forest Sciences is an AI-driven biotechnology company focused on accelerating drug discovery through advanced computational methods and open-source software. The company's core technology is the Prisyn platform, which utilizes deep learning and physics-based simulations to predict the properties and efficacy of potential drug candidates. Deep Forest Sciences is closely integrated with the open-source community, as its founder is the lead developer of DeepChem, a widely used library for deep learning in the life sciences. By combining proprietary software with open-source foundations, the company provides pharmaceutical partners with tools to navigate complex chemical spaces and optimize lead compounds. Their business model emphasizes collaborative research and development to bring novel small molecule therapeutics to market more efficiently.